Coming of age: the artificial pancreas for type 1 diabetes
The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-responsive insulin delivery above and below a preset insulin amount informed by sensor glucose readings differentia...
Gespeichert in:
| Veröffentlicht in: | Diabetologia 2016-09, Vol.59 (9), p.1795-1805 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1805 |
|---|---|
| container_issue | 9 |
| container_start_page | 1795 |
| container_title | Diabetologia |
| container_volume | 59 |
| creator | Thabit, Hood Hovorka, Roman |
| description | The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-responsive insulin delivery above and below a preset insulin amount informed by sensor glucose readings differentiates closed-loop systems from conventional, threshold-suspend and predictive-suspend insulin pump therapy. Insulin requirements in type 1 diabetes can vary between one-third–threefold on a daily basis. Closed-loop systems accommodate these variations and mitigate the risk of hypoglycaemia associated with tight glucose control. In this review we focus on the progress being made in the development and evaluation of closed-loop systems in outpatient settings. Randomised transitional studies have shown feasibility and efficacy of closed-loop systems under supervision or remote monitoring. Closed-loop application during free-living, unsupervised conditions by children, adolescents and adults compared with sensor-augmented pumps have shown improved glucose outcomes, reduced hypoglycaemia and positive user acceptance. Innovative approaches to enhance closed-loop performance are discussed and we also present the outlook and strategies used to ease clinical adoption of closed-loop systems. |
| doi_str_mv | 10.1007/s00125-016-4022-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4969330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4145695361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c569t-5fc30defc65ac10375b345f009b5127b0e0b8769719435495122a6b9e60d64113</originalsourceid><addsrcrecordid>eNqNkdFrFDEQxoNY7Fn9A3yRgC--rM4k2WTTB0EOq0KhLy34FrK52WvK3uZM9gr97831aqmC4NNAvt98M5mPsTcIHxDAfCwAKNoGUDcKhGjUM7ZAJUUDSnTP2WIvN9jpH8fsZSk3ACBbpV-wY2GkVtaaBTtdpk2c1jwN3K_plM_XxH2e4xBD9CPf-ilk8oUPKfP5bksc-Sr6nmYqr9jR4MdCrx_qCbs6-3K5_NacX3z9vvx83oRW27lphyBhRUPQrQ8I0rS9VO0AYPsWhemBoO-MtgatquvZ-ii87i1pWGmFKE_Yp4PvdtdvaBVomrMf3TbHjc93Lvno_lSmeO3W6dYpq62UUA3ePxjk9HNHZXabWAKNo58o7YrDDtFCBbv_QKHToI0xFX33F3qTdnmql7g3rKdGIyqFByrkVEqm4XFvBLcP0R1CdDVEtw_Rqdrz9umHHzt-p1YBcQBKlaY15Sej_-n6C_w1pDM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1811035172</pqid></control><display><type>article</type><title>Coming of age: the artificial pancreas for type 1 diabetes</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Thabit, Hood ; Hovorka, Roman</creator><creatorcontrib>Thabit, Hood ; Hovorka, Roman</creatorcontrib><description>The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-responsive insulin delivery above and below a preset insulin amount informed by sensor glucose readings differentiates closed-loop systems from conventional, threshold-suspend and predictive-suspend insulin pump therapy. Insulin requirements in type 1 diabetes can vary between one-third–threefold on a daily basis. Closed-loop systems accommodate these variations and mitigate the risk of hypoglycaemia associated with tight glucose control. In this review we focus on the progress being made in the development and evaluation of closed-loop systems in outpatient settings. Randomised transitional studies have shown feasibility and efficacy of closed-loop systems under supervision or remote monitoring. Closed-loop application during free-living, unsupervised conditions by children, adolescents and adults compared with sensor-augmented pumps have shown improved glucose outcomes, reduced hypoglycaemia and positive user acceptance. Innovative approaches to enhance closed-loop performance are discussed and we also present the outlook and strategies used to ease clinical adoption of closed-loop systems.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-016-4022-4</identifier><identifier>PMID: 27364997</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Algorithms ; Blood Glucose - drug effects ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 1 - surgery ; Human Physiology ; Humans ; Insulin - therapeutic use ; Internal Medicine ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Pancreas, Artificial ; Review</subject><ispartof>Diabetologia, 2016-09, Vol.59 (9), p.1795-1805</ispartof><rights>The Author(s) 2016</rights><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c569t-5fc30defc65ac10375b345f009b5127b0e0b8769719435495122a6b9e60d64113</citedby><cites>FETCH-LOGICAL-c569t-5fc30defc65ac10375b345f009b5127b0e0b8769719435495122a6b9e60d64113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-016-4022-4$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-016-4022-4$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,776,780,788,881,27899,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27364997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thabit, Hood</creatorcontrib><creatorcontrib>Hovorka, Roman</creatorcontrib><title>Coming of age: the artificial pancreas for type 1 diabetes</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-responsive insulin delivery above and below a preset insulin amount informed by sensor glucose readings differentiates closed-loop systems from conventional, threshold-suspend and predictive-suspend insulin pump therapy. Insulin requirements in type 1 diabetes can vary between one-third–threefold on a daily basis. Closed-loop systems accommodate these variations and mitigate the risk of hypoglycaemia associated with tight glucose control. In this review we focus on the progress being made in the development and evaluation of closed-loop systems in outpatient settings. Randomised transitional studies have shown feasibility and efficacy of closed-loop systems under supervision or remote monitoring. Closed-loop application during free-living, unsupervised conditions by children, adolescents and adults compared with sensor-augmented pumps have shown improved glucose outcomes, reduced hypoglycaemia and positive user acceptance. Innovative approaches to enhance closed-loop performance are discussed and we also present the outlook and strategies used to ease clinical adoption of closed-loop systems.</description><subject>Algorithms</subject><subject>Blood Glucose - drug effects</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 1 - surgery</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Insulin - therapeutic use</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Pancreas, Artificial</subject><subject>Review</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkdFrFDEQxoNY7Fn9A3yRgC--rM4k2WTTB0EOq0KhLy34FrK52WvK3uZM9gr97831aqmC4NNAvt98M5mPsTcIHxDAfCwAKNoGUDcKhGjUM7ZAJUUDSnTP2WIvN9jpH8fsZSk3ACBbpV-wY2GkVtaaBTtdpk2c1jwN3K_plM_XxH2e4xBD9CPf-ilk8oUPKfP5bksc-Sr6nmYqr9jR4MdCrx_qCbs6-3K5_NacX3z9vvx83oRW27lphyBhRUPQrQ8I0rS9VO0AYPsWhemBoO-MtgatquvZ-ii87i1pWGmFKE_Yp4PvdtdvaBVomrMf3TbHjc93Lvno_lSmeO3W6dYpq62UUA3ePxjk9HNHZXabWAKNo58o7YrDDtFCBbv_QKHToI0xFX33F3qTdnmql7g3rKdGIyqFByrkVEqm4XFvBLcP0R1CdDVEtw_Rqdrz9umHHzt-p1YBcQBKlaY15Sej_-n6C_w1pDM</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Thabit, Hood</creator><creator>Hovorka, Roman</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160901</creationdate><title>Coming of age: the artificial pancreas for type 1 diabetes</title><author>Thabit, Hood ; Hovorka, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c569t-5fc30defc65ac10375b345f009b5127b0e0b8769719435495122a6b9e60d64113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Algorithms</topic><topic>Blood Glucose - drug effects</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 1 - surgery</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Insulin - therapeutic use</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Pancreas, Artificial</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thabit, Hood</creatorcontrib><creatorcontrib>Hovorka, Roman</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thabit, Hood</au><au>Hovorka, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coming of age: the artificial pancreas for type 1 diabetes</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>59</volume><issue>9</issue><spage>1795</spage><epage>1805</epage><pages>1795-1805</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose-responsive insulin delivery above and below a preset insulin amount informed by sensor glucose readings differentiates closed-loop systems from conventional, threshold-suspend and predictive-suspend insulin pump therapy. Insulin requirements in type 1 diabetes can vary between one-third–threefold on a daily basis. Closed-loop systems accommodate these variations and mitigate the risk of hypoglycaemia associated with tight glucose control. In this review we focus on the progress being made in the development and evaluation of closed-loop systems in outpatient settings. Randomised transitional studies have shown feasibility and efficacy of closed-loop systems under supervision or remote monitoring. Closed-loop application during free-living, unsupervised conditions by children, adolescents and adults compared with sensor-augmented pumps have shown improved glucose outcomes, reduced hypoglycaemia and positive user acceptance. Innovative approaches to enhance closed-loop performance are discussed and we also present the outlook and strategies used to ease clinical adoption of closed-loop systems.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27364997</pmid><doi>10.1007/s00125-016-4022-4</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-186X |
| ispartof | Diabetologia, 2016-09, Vol.59 (9), p.1795-1805 |
| issn | 0012-186X 1432-0428 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4969330 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Algorithms Blood Glucose - drug effects Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - surgery Human Physiology Humans Insulin - therapeutic use Internal Medicine Medicine Medicine & Public Health Metabolic Diseases Pancreas, Artificial Review |
| title | Coming of age: the artificial pancreas for type 1 diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A22%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coming%20of%20age:%20the%20artificial%20pancreas%20for%20type%201%20diabetes&rft.jtitle=Diabetologia&rft.au=Thabit,%20Hood&rft.date=2016-09-01&rft.volume=59&rft.issue=9&rft.spage=1795&rft.epage=1805&rft.pages=1795-1805&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-016-4022-4&rft_dat=%3Cproquest_pubme%3E4145695361%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1811035172&rft_id=info:pmid/27364997&rfr_iscdi=true |